- Datum22.04.2024
- Uhrzeit19:00 - 20:00 Uhr
- VeranstalterBNP Paribas
Du willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnenHikma Pharmaceuticals PLC Kurse
Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
---|---|---|---|---|---|---|
L&S | VK | |||||
Tradegate | VK | |||||
Stuttgart | VK |
Passende Produkte
WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
---|
Wertentwicklung (L&S)
Wikifolio
Passender Service zu Hikma Pharmaceuticals PLC
Webinar zu Hikma Pharmaceuticals PLC
Kursinformationen (L&S)
- Tagestief / Hoch (€)-
- 52W-Tief / Hoch (€)19,200-25,800
- Jahrestief / Hoch (€)20,000-25,200
- Schlusskurs (Vortag)
- Eröffnungskurs
Wichtigste Eigenschaften
Dividenden von Hikma Pharmaceuticals PLC
Termine von Hikma Pharmaceuticals PLC
- Aug8Hikma Pharmaceuticals PLCQ2 2024 Earnings Release
- Feb20Hikma Pharmaceuticals PLCQ4 2024 Earnings Release
- Aug8Hikma Pharmaceuticals PLCQ2 2025 Earnings Release
Beschreibung
Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.